Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-02

Clinical Trial Update: Hepatectomy Versus Chemoembolization for Resectable Hepatocellular Carcinoma Beyond Milan Criteria [Phase 4]

View source ↗

Summary

Phase 4 trial comparing hepatectomy to chemoembolization for resectable hepatocellular carcinoma beyond Milan criteria; status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sun Yat-sen University | Conditions: Resectable Hepatocellular Carcinoma Beyond Milan Criteria | Phase 4 | Status: UNKNOWN